ICA1L stabilizes #LRP1 to mitigate Aβ pathology in #AlzheimersDisease
Liang Chen, Kai Zhuang...Jiechao Zhou, Weiwei Gao, Jie Zhang #amyloid
@molneurodegen.bsky.social
@molneurodegen.bsky.socialICA1L stabilizes #LRP1 to mitigate Aβ pathology in #AlzheimersDisease
Liang Chen, Kai Zhuang...Jiechao Zhou, Weiwei Gao, Jie Zhang #amyloid
@stressmarq.bsky.socialProduct Citation 🧩
The APOE3-Christchurch mutation alters #amyloid plaque structure & reduces neuritic damage. StressMarq’s Aβ 1-42 Peptide was utilized to study Aβ aggregation in response to astrocyte-conditioned media.
Paper 🎲 https://go.nature.com/4n9I3hx
Aβ 1-42 🎯 https://bit.ly/3OXpil2
@boblivion.bsky.social
@newsen.bsky.socialNuravax and Institute for Molecular Medicine Release Phase 1 Results for Experimental Vaccine Against Amyloid-Beta #United_States #Irvine #Nuravax #AV-1959R #Amyloid-Beta_Vaccine
@sigtrans-sttt.bsky.social
@foodnourish.bsky.social📣 New Podcast! "Detecting Alzheimer's 20 Years Before Symptoms: The Hidden Roadmap" on @Spreaker #alzheimer #amyloid #apoe4 #biomarkers #brain #cognition #dementia #diagnosis #genetics #health #longevity #medicine #memory #neurology #neuroscience #prevention #research #sleep #tau #wellness
@sigtrans-sttt.bsky.social
@pcavanderwel.bsky.socialWebinar: "Proteostasis Consortium Seminar:
Amyloid Polymorphism: More than just the Fibril Core”. by Sheena Radford @radford-lab.bsky.social
(presumably about the cruciial ‘fuzzy coat’ of #amyloid fibrils )
Sep 30, 2026; #Proteostasis consortium seminar
@molneurodegen.bsky.socialDynamic [18F]PI-2620 recording facilitates prediction of β- #amyloid positivity and simultaneous staging of tau and #neurodegeneration
Johannes Gnörich, Julia Kusche-Palenga, Agnes Kling...Matthias Brendel @lmu.de #neuroimaging #tauopathies
@molneurodegenadvnc.bsky.socialAs part of our inaugural review series!
Targeting protein aggregate co-pathologies in #neurodegeneration: a viable therapeutic strategy?
Silas A. Buck, Sidharth S. Madhavan, Laurie H. Sanders
@dukemedschool.bsky.social #TDP43 #tauopathy #amyloid #alphasynuclein
@joshmitchellmd.bsky.socialHonored to be able to partner with @americanheart.bsky.social
to discuss workable strategies to improve #amyloid recognition. We will discuss early recognition, barriers, and optimal system based practices. Register at lnkd.in/gTdr88UB. @washumedicine.bsky.social @pennmedicine.bsky.social
@longevitytech.bsky.socialPrecivityAD2 can now be used in symptomatic adults as young as 40, giving doctors a blood draw instead to check for amyloid plaques.
Link as first comment.
